Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA top lawyer: Gerald F. Masoudi is FDA's new chief counsel, the agency says Oct. 16. He replaces Sheldon Bradshaw, who resigned from the post to go into private practice in September. Masoudi has been with the Department of Justice since 2005, but prior to that he was FDA deputy chief counsel under Daniel Troy. He served as acting chief counsel when Troy left in November 2004 until Bradshaw took over the following April (1"The Gray Sheet" Nov. 15, 2004, p. 9)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel